Perfil
Stuart Chaffee is an Independent Director at ABG Acquisition Corp.
I.
He was previously the Chief Financial Officer at Praxis Precision Medicines, Inc. in 2020 and the Head of Business Operations at Kymera Therapeutics, Inc. from 2016 to 2017.
Dr. Chaffee holds an MBA from The Wharton School of the University of Pennsylvania.
Cargos activos de Stuart Chaffee
| Empresas | Cargo | Inicio |
|---|---|---|
| ABG ACQUISITION CORP. I | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Stuart Chaffee.
| Empresas | Cargo | Fin |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Director Financiero/CFO | 02/12/2020 |
| KYMERA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2017 |
Formación de Stuart Chaffee.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
ABG Acquisition Corp. I
ABG Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
- Bolsa de valores
- Insiders
- Stuart Chaffee
















